Patient-friendly summary
If you read nothing else
Bottom line
This treatment seems promising for pain relief and is worth discussing with your provider.
Preliminary evidenceAsk your provider
- What are my options for treating my paraspinal MPS?
- Could the PFPB be a good choice for me?
- What are the potential benefits and risks of the PFPB?
Try this week
- Ask your doctor about the PFPB if you have persistent MPS pain.
- Keep track of your pain levels before and after trying new treatments.
How well it works
The PFPB showed significant pain reduction in a small case series.
NRS 0–10
Pain reduced from 9 to 1
Study Summary
Background
Myofascial pain syndrome (MPS) affecting the paraspinal muscles is a common reason for emergency department visits, but existing treatments often provide incomplete or short-lived relief. Traditional approaches like oral pain medications and trigger point injections frequently fail to address the underlying problem. Recent research suggests that fascia (connective tissue surrounding muscles) plays a more important role in pain generation than muscle tissue alone. The fascia contains numerous pain receptors and may become thickened, scarred, or stuck together in people with chronic pain.
This understanding has led researchers to develop treatments that specifically target fascial tissue rather than just muscle.
What They Did
Emergency medicine physicians at the University of Pennsylvania developed a new ultrasound-guided procedure called the paravertebral fascial plane block (PFPB). This technique combines several elements: injection of local anesthetic (bupivacaine) mixed with saline and sometimes steroid medication into the space between muscle layers, followed by controlled needling of the fascial tissue under ultrasound guidance. They tested this approach on 11 adult patients who came to the emergency department with severe paraspinal muscle pain that hadn't responded adequately to standard pain medications. The researchers measured pain scores before the procedure, at hospital discharge, and 24-48 hours later by phone follow-up.
They performed the procedure at different spinal levels (neck, mid-back, and lower back) depending on where patients had the most pain.
What They Found
All 11 patients experienced dramatic pain reduction. Before the procedure, patients rated their pain as 9 out of 10 on average. Immediately after the procedure at discharge, pain scores dropped to 3 out of 10 - a 67% reduction. At follow-up 24-48 hours later, pain scores were even lower at 1 out of 10 - an 89% reduction from baseline.
Eight out of 10 patients with follow-up data (80%) reported their pain relief was either sustained or had improved further since leaving the hospital. No complications occurred, and none of the treated patients returned to any emergency department in their health system within 48 hours.
What This Means
This study suggests that targeting fascial tissue rather than muscle alone may be a more effective approach for treating stubborn paraspinal pain. The PFPB technique appears to provide both immediate and sustained pain relief for patients whose pain hasn't responded to conventional treatments. Because the procedure uses ultrasound guidance and stays in superficial tissue planes, it may be safer than deeper injection techniques. However, this was a small study without a control group, so larger controlled trials are needed to confirm these promising results and determine exactly which components of the procedure are most important for pain relief.
Results Comparison
NRS Pain Score (0-10)
pointsKey Findings
| Finding | Detail | Impact |
|---|---|---|
| Dramatic immediate pain reduction with PFPB procedure | Median pain scores decreased from 9/10 to 3/10 at discharge (67% reduction, p=0.004) | High |
| Sustained pain relief at short-term follow-up | Pain scores further improved to 1/10 at 24-48 hours (89% total reduction, p=0.006) | High |
| Excellent safety profile with no complications | No procedural adverse events and no emergency department returns within 48 hours | Medium |
| Technique applicable across all spinal levels | Successfully performed at cervical (18%), thoracic (36%), and lumbar (45%) levels | Medium |
| Majority experienced sustained or improved relief | 80% of patients (8/10) reported maintained or further improved pain at follow-up | High |
Median pain scores decreased from 9/10 to 3/10 at discharge (67% reduction, p=0.004)
Pain scores further improved to 1/10 at 24-48 hours (89% total reduction, p=0.006)
No procedural adverse events and no emergency department returns within 48 hours
Successfully performed at cervical (18%), thoracic (36%), and lumbar (45%) levels
80% of patients (8/10) reported maintained or further improved pain at follow-up
Strengths
- Novel technique addressing fascial pain mechanisms
- Consistent dramatic pain reduction across all patients
- No complications or adverse events reported
- Technique applicable across multiple spinal levels
Limitations
- Very small sample size (11 patients) limits generalizability
- No control group to compare effectiveness against standard care
- Short follow-up period (24-48 hours) - no long-term data
- Single-center study with fellowship-trained physicians may not reflect broader applicability
Key Takeaways for Patients
What This Means for You
- 01A new ultrasound-guided injection technique targeting tissue around the spine muscles shows promise for stubborn back and neck pain
- 02The procedure appears safe with no complications reported in this small study
- 03Pain relief was dramatic and sustained for at least 2 days after treatment
- 04This approach may help patients whose pain hasn't responded to standard medications
- 05Larger studies are needed to confirm these promising early results
Read the Full Paper
Access the complete peer-reviewed study from American Journal of Emergency Medicine
View Full Study